EarningsQ2 2024 Earnings Report

Heron Therapeutics (AXD2) Q2 2024 Earnings Report

4 Followers

DE:AXD2 Q2 2024 EPS Results

Actual EPS-€0.05

Consensus EPS-€0.03

Beat/MissMissed by -€0.02

One Year Ago EPS-€0.31

Actual Revenue€32.15M

Expected Revenue€32.21M

Beat/MissMissed by -€58.90K

YoY Revenue Growth+13.42%

QuarterQ2 2024

Date08/06/2024

TimeAfter Close

Conference CallTuesday, August 6, 2024

DE:AXD2 Upcoming Earnings

Heron Therapeutics's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

DE:AXD2 Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	-0.02 / -	-0.089	―
Aug 10, 2026	2026 (Q2)	>-0.01 / -0.03	-0.018	-50.00% (>-0.01)
May 11, 2026	2026 (Q1)	-0.02 / -0.04	0.009	-500.00% (-0.04)
Feb 26, 2026	2025 (Q4)	-0.02 / -0.02	0.018	-200.00% (-0.04)
Nov 04, 2025	2025 (Q3)	-0.01 / -0.09	-0.027	-233.33% (-0.06)
Aug 08, 2025	2025 (Q2)	>-0.01 / -0.02	-0.054	66.67% (+0.04)
May 06, 2025	2025 (Q1)	>-0.01 / <0.01	-0.018	150.00% (+0.03)
Feb 27, 2025	2024 (Q4)	-0.03 / 0.02	-0.062	128.57% (+0.08)
Nov 12, 2024	2024 (Q3)	-0.03 / -0.03	-0.152	82.35% (+0.12)
Aug 06, 2024	2024 (Q2)	-0.03 / -0.05	-0.312	82.86% (+0.26)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed